http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105017222-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105017222-B
titleOfInvention A kind of preparation method of Imatinib impurity
abstract The invention discloses a kind of preparation method of Imatinib impurity.This method is with 1; 4 pairs of (4 carboxybenzyl) piperazines are raw material; in N; N DICs, 1 hydroxybenzotriazole, N; N diisopropylethylamine with Imatinib amine react under conditions of existing obtains double [4 [4 methyl 3 [[base of 4 (base of the pyridine 3) pyrimidine 2] amino] phenyl] carbamoyl] benzyl diethylenediamines of Imatinib impurity Isosorbide-5-Nitrae.The preparation method of the present invention is simple, and reaction condition requires low, and the purity of product is high, high income, suitable industrialized production.The impurity of synthesis can be used for the Qualitative and quantitative analysis of impurity, so as to improve the drug safety of Imatinib.
priorityDate 2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010133976-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011095835-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452650975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416172369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17606055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424628937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16741201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135399369

Total number of triples: 48.